Control of Alginate Core Size in Alginate-Poly (Lactic-Co-Glycolic) Acid Microparticles

Core-shell alginate-poly (lactic-co-glycolic) acid (PLGA) microparticles are potential candidates to improve hydrophilic drug loading while facilitating controlled release. This report studies the influence of the alginate core size on the drug release profile of alginate-PLGA microparticles and its...

Full description

Saved in:
Bibliographic Details
Main Authors: Lio, Daniel, Yeo, David, Xu, Chenjie
Other Authors: School of Chemical and Biomedical Engineering
Format: Article
Language:English
Published: 2016
Subjects:
Online Access:https://hdl.handle.net/10356/81905
http://hdl.handle.net/10220/39715
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Nanyang Technological University
Language: English
id sg-ntu-dr.10356-81905
record_format dspace
spelling sg-ntu-dr.10356-819052023-12-29T06:51:12Z Control of Alginate Core Size in Alginate-Poly (Lactic-Co-Glycolic) Acid Microparticles Lio, Daniel Yeo, David Xu, Chenjie School of Chemical and Biomedical Engineering Drug delivery Core-shell structure Alginate-PLGA microparticles Core-shell alginate-poly (lactic-co-glycolic) acid (PLGA) microparticles are potential candidates to improve hydrophilic drug loading while facilitating controlled release. This report studies the influence of the alginate core size on the drug release profile of alginate-PLGA microparticles and its size. Microparticles are synthesized through double-emulsion fabrication via a concurrent ionotropic gelation and solvent extraction. The size of alginate core ranges from approximately 10, 50, to 100 μm when the emulsification method at the first step is homogenization, vortexing, or magnetic stirring, respectively. The second step emulsification for all three conditions is performed with magnetic stirring. Interestingly, although the alginate core has different sizes, alginate-PLGA microparticle diameter does not change. However, drug release profiles are dramatically different for microparticles comprising different-sized alginate cores. Specifically, taking calcein as a model drug, microparticles containing the smallest alginate core (10 μm) show the slowest release over a period of 26 days with burst release less than 1 %. Published version 2016-01-19T07:48:21Z 2019-12-06T14:42:46Z 2016-01-19T07:48:21Z 2019-12-06T14:42:46Z 2016 Journal Article Lio, D., Yeo, D., & Xu, C. (2016). Control of Alginate Core Size in Alginate-Poly (Lactic-Co-Glycolic) Acid Microparticles. Nanoscale Research Letters, 11(1), 9-. 1931-7573 https://hdl.handle.net/10356/81905 http://hdl.handle.net/10220/39715 10.1186/s11671-015-1222-7 26745977 en Nanoscale Research Letters © 2016 Lio et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. 6 p. application/pdf
institution Nanyang Technological University
building NTU Library
continent Asia
country Singapore
Singapore
content_provider NTU Library
collection DR-NTU
language English
topic Drug delivery
Core-shell structure
Alginate-PLGA microparticles
spellingShingle Drug delivery
Core-shell structure
Alginate-PLGA microparticles
Lio, Daniel
Yeo, David
Xu, Chenjie
Control of Alginate Core Size in Alginate-Poly (Lactic-Co-Glycolic) Acid Microparticles
description Core-shell alginate-poly (lactic-co-glycolic) acid (PLGA) microparticles are potential candidates to improve hydrophilic drug loading while facilitating controlled release. This report studies the influence of the alginate core size on the drug release profile of alginate-PLGA microparticles and its size. Microparticles are synthesized through double-emulsion fabrication via a concurrent ionotropic gelation and solvent extraction. The size of alginate core ranges from approximately 10, 50, to 100 μm when the emulsification method at the first step is homogenization, vortexing, or magnetic stirring, respectively. The second step emulsification for all three conditions is performed with magnetic stirring. Interestingly, although the alginate core has different sizes, alginate-PLGA microparticle diameter does not change. However, drug release profiles are dramatically different for microparticles comprising different-sized alginate cores. Specifically, taking calcein as a model drug, microparticles containing the smallest alginate core (10 μm) show the slowest release over a period of 26 days with burst release less than 1 %.
author2 School of Chemical and Biomedical Engineering
author_facet School of Chemical and Biomedical Engineering
Lio, Daniel
Yeo, David
Xu, Chenjie
format Article
author Lio, Daniel
Yeo, David
Xu, Chenjie
author_sort Lio, Daniel
title Control of Alginate Core Size in Alginate-Poly (Lactic-Co-Glycolic) Acid Microparticles
title_short Control of Alginate Core Size in Alginate-Poly (Lactic-Co-Glycolic) Acid Microparticles
title_full Control of Alginate Core Size in Alginate-Poly (Lactic-Co-Glycolic) Acid Microparticles
title_fullStr Control of Alginate Core Size in Alginate-Poly (Lactic-Co-Glycolic) Acid Microparticles
title_full_unstemmed Control of Alginate Core Size in Alginate-Poly (Lactic-Co-Glycolic) Acid Microparticles
title_sort control of alginate core size in alginate-poly (lactic-co-glycolic) acid microparticles
publishDate 2016
url https://hdl.handle.net/10356/81905
http://hdl.handle.net/10220/39715
_version_ 1787136728514953216